Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient preference for oral versus intravenous vinorelbine in advanced non-small cell lung cancer
2012-003544-68Phase 4Completed
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Started Oct 2012; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2012-003544-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003544-68.